Sensor Optimization of Cardiac Resynchronization Therapy Response

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

January 31, 2016

Study Completion Date

June 30, 2016

Conditions
Heart Failure
Interventions
DEVICE

Cardiac Resynchronization Therapy

All study patients were evaluated for the optimal atrial-ventricular (AV) programmed interval using various methods.

Trial Locations (9)

43210

The Ohio State University, Columbus

45014

Mercy Hospital Fairfield, Fairfield

50314-3017

Iowa Heart Center, Des Moines

V8R 4R2

Victoria Cardiac Arrhythmia Trials, Victoria

K1Y 4W7

Ottawa Heart Institute, Ottawa

GIV 4G5

Institut Universitaire de Cardiologie et de Pneumologie de Québec, Québec

Unknown

Grantham Hospital, Hong Kong

Queen Mary Hospital, Hong Kong

SE5 9RS

Kings College Hospital, London

All Listed Sponsors
lead

Medtronic Cardiac Rhythm and Heart Failure

INDUSTRY

NCT01832493 - Sensor Optimization of Cardiac Resynchronization Therapy Response | Biotech Hunter | Biotech Hunter